POSTERBEITRÄGE 2024
ISTH 2024 | 22 June – 26 June 2024 | Bangkok
smart medication Gene – a collaboration and documentation tool for the patient journey according to hub & spoke modell in gene therapy of hemophilia A/B
A. Rösch, D. Schmoldt
ISTH 2024 | 22 June – 26 June 2024 | Bangkok
The change in factor VIII therapy since the introduction of mandatory pharmacy reporting in the GSAV in Germany – a retrospective data analysis from smart medication ScanDoc over 3 years
A. Rösch, D. Schmoldt
GTH 2024 | 27 Februar – 1 März 2024 | Wien
smart medication Gene – a collaboration and documentation tool for the patient journey according to hub & spoke modell in gene therapy of hemophilia A/B
A. Rösch, D. Schmoldt
The change in factor VIII therapy since the introduction of mandatory pharmacy reporting in the GSAV in Germany – a retrospective data analysis from smart medication ScanDoc over 3 years
A. Rösch, D. Schmoldt
POSTERBEITRÄGE 2023
ISTH 2023
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication
W. Mondorf, H. Eichler, R. Fischer, K. Holstein, R. Klamroth, W. Miesbach, H. Richter, K. Trautmann, U. Sachs, C. Escuriola-Ettingshausen
67th Annual Meeting of the Society of Thrombosis and Hemostasis Research
GTH 2023 | 21 – 24 Februar | Frankfurt am Main
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Follow-up evaluation of real-life-data documented by smart medication eDiary
W. Mondorf, H. Eichler, R. Fischer, K. Holstein, R. Klamroth, H. Richter, U. Sachs, C. Escuriola-Ettingshausen
A. Rösch, D. Schmoldt, W. Mondorf
At the forefront of the introduction of gene therapy in hemophilia A and B: Design and implementation of an innovative software platform („smart medication Gene“) for gene therapy
A. Rösch, D. Schmoldt, L. De Witte
POSTERBEITRÄGE 2022
53. Hamburger Hämophilie Symposium
At the forefront of developing pioneering advances in gene therapy: Conceptualization and implementation of an innovative software platform (“Gene”) for gene therapy in hemophilia
A. Rösch, D. Schmoldt, L. De Witte
66th Annual Meeting of the Society of Thrombosis and Hemostasis Research
GTH 2022 | 1 – 4 March Leipzig
smart medication – Digital Ecosystem for the Care of Patients with Hemophilia
A. Rösch, D. Schmoldt, L. De Witte
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, U. Sachs
Impact of lockdown on patients with severe hemophilia A during the Covid-19 pandemic in Germany on therapy and bleeding rates based on Real-life-data from smart medication
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, H. Richter
POSTERBEITRÄGE 2021
65th Annual Meeting of the Society of Thrombosis and Hemostasis Research
GTH 2021 | 22 – 26 February (online)
Development of annual joint bleeds and factor consumption during the last 6 years in 14 hemophilia centers – real life data from electronic documentation smart medication
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, C. Hart, B. Kemkes-Matthes, R. Klamroth, B. Krammer-Steiner, A. Nimtz-Talaska, K. Severin, C. Wermes, H. Richter
R. Fischer, H. Eichler, C. Escuriola-Ettinghausen, K. Holstein, C. Hart, B. Kemkes-Matthes, R. Klamroth, B. Krammer-Steinber, W. Mondorf, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart medication
K. Holstein, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, C. Hart, B. Kemkes-Matthes, R. Klamroth, B. Krammer-Steiner, W. Mondorf, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes
smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patient
A. Rösch, D. Schmoldt
POSTERBEITRÄGE 2020
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
64th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 18.-12. Februar 2020 in Bremen
Telehealth in Haemophilia Treatment – Use and Recommendation Intentions of Patients and Physicians
T. Driebe, P. Alpar, C. Wermes. W. Mondorf (Poster Nummer: P02-1)
R. Fischer, H. Eichler, C. Escuriola-Ettinghausen, C. Hart, K. Holstein, B. Kemkes-Matthes, R. Klamroth, W. Mondorf, A. Nimtz-Talaska, H. Richter, K. Severin, B. Krammer-Steiner, C. Wermes, VFTH e.V. (Poster Nummer: P02-5)
Comparison of bleeding rate and factor consumption between extended and short half-life factor VIII in real life according to electronic documentation smart medication.
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, C. Hart, K. Holstein, B. Kemkes-Matthes, R. Klamroth, B. Krammer-Steiner, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes, VFTH e.V. (Poster Nummer: P06-1)
Five-year follow-up in haemophilia care comparing real life data from electronic documentation smart medication.
W. Mondorf, H. Richter, C. Wermes, R. Klamroth, K. Severin, K. Holstein, C. Escuriola-Ettinghausen, C. Hart, R. Fischer, B. Kemkes-Matthes, B. Krammer-Steiner, A. Nimtz-Talaska, H. Eichler, VFTH e.V. (Poster Nummer: P06-2)
Electronic diary smart medication for patients with haemophilia in the context of the Digital Care Act (DigitaleVersorgung-Gesetz, DVG)
A. Roesch, D. Schmoldt, W. Mondorf (Poster Nummer: P06-9)
POSTERBEITRÄGE 2019
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
63th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 27. Februar -2. März 2019 in Berlin
Comparison of electronic documentation with smart medication between 2014 and 2017.
Annual joint bleeding rate (AJBR) and annual factor VIII/IX consumption (AFC) differ widely among patients with severe haemophilia. The year to year pattern may, however, be similar.
W. Mondorf, H. Eichler, R. Fischer, K. Holstein, R. Klamroth, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes, VFTH e.V. (Poster Nummer: P03-1)
W. Mondorf, B. Schmoldt, A. Rösch (Poster Nummer: P01-7)
Impact of GDPR (DSGVO) on smart medication electronic patient diary.
May, 25th 2018 the GDPR (english: General Data Protection Regulation, German DSGVO: Datenschutz-Grundverordnung) was coming into effect throughout the European Community. It is shown how the new regulation impacts the smart medication platform in respect of data processing of personal health information.
A. Rösch, D. Schmoldt, W. Mondorf, R. Fischer. (Poster Nummer: P09-10)
smart medication – a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary.
smart medication was successfully implemented in haemophilia home treatment. Until now patients enter treatment data using either a smartphone-app or a web-browser. The aim of this study was to analyse and evaluate the use of speech recognition as an additional interface to the electronic diary.
A. Rösch, D. Schmoldt, W. Mondorf, R. Fischer (Poster Nummer: P09-9)
smart medication – a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary.
A. Rösch, D. Schmoldt, W. Mondorf, R. Fischer (Poster Nummer: P09-9)
POSTERBEITRÄGE 2018
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
62th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 20.-23. Februar 2018 in Wien
An advanced reporting module within the smart medication platform simplifies mandatory reporting into the German Hemophilia Registry (DHR).
A. Rösch, D. Schmoldt, W. Mondorf, Eichler H., Fischer R., VFTH e.V. (Poster Num: P045)
Ensuring information security for the electronic patient diary smart medication by applying an Information Security Management System(ISMS) based on the international standards ISO/IEC 27001 and ISO/IEC 27799.
A. Rösch, D. Schmoldt, W. Mpndorf, Fischer R., VFTH e.V. (Poster Num: P052)
Prophylactic vs. on demand treatment in haemophilia patients – real life data according to electronic diary smart medication.
Fischer R., Eichler H., K. Holstein, R. Klamroth, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes, W. Mondorf, VFTH e.V. (Poster Num: P060)
Bleeding vs. Factor VIII/IX consumption – comparison of annual real-life results between 2014 and 2016 according to electronic diary smart medication.
Mondorf W., Eichler H., Fischer R., Holstein K., Klamroth R., Nimtz-Talaska A., Severin K., Wermes C., VFTH e.V. (Poster Num: P064)
POSTERBEITRÄGE 2017
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
61th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 15.-18. Februar 2017 in Basel
Comparison of data security of the electronic patient diary smart medication with manual documentation in a paper diary.
A. Rösch, W. Mondorf, R. Fischer, D. Schmoldt (Poster Num: 70)
Annual Bleeding vs. Factor VIII/IX consumption – comparison of result in 2014 and 2015 according to electronic diary smart medication.
R. Fischer, H. Eichler, K. Holstein, R. Klamroth, W. Mondorf, A. Nimtz-Talaska,H. Richter, K. Severin, C. Wermes, VFTH e.V. (Poster Num: 53)
Monitoring of perioperative factor VIII treatment in a remote hospital by electronic diary smart medication.
W. Mondorf, VFTH e.V. (Poster Num: 37)
POSTERBEITRÄGE 2016
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
60th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 17.-20. Februar 2016 in Münster/Germany
Annual Bleeding vs. Factor VIII/IX consumption – what is the optimal dose according to electronic diary smart medication.
Mondorf W., Eichler H., Fischer R., Holstein K., Klamroth R., Nimtz-Talaska A., Pollmann H., Wermes C., VFTH e.V. (Poster Num: P08-9)
Prophylactic vs. on demand treatment in haemophilia patients – real life data according to electronic diary smart medication.
Fischer R., Eichler H., Holstein K., Klamroth R., Nimitz-Talaska A., Pollman H., Severin K., Wermes C., Mondorf W. (Poster Num: P02-7)
Daytime of prophylaxis and bleeding frequency: real life data from the electronic diary smart medication.
Holstein K., Klamroth R., Fischer R., Wermes C., Severin K., Nimtz-Talaska A., Eichler H., Pollmann H., Mondorf W. (Poster Num: P08-3)
POSTERBEITRÄGE 2014
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
WFH 2014 | World Congress | 11.-15. Mai 2015 in Melbourne
The electronic diary smart medication allows a rapid and comprehensive overview of haemophilia home treatment. The electronic diary smart medication allows online surveillance of haemophilia home treatment. Adherences to documentation and treatment recommendations as well as subsequent bleeding patterns were analyzed according to two years experiences of two German haemophilia centers.”
Authors: W. Mondorf, C. Mondorf, H. Pollmann, B. Siegmund, A. Rösch, D. Schmoldt
Study centre Haemostas-Frankfurt, Topic: Hemophilia Programs and Organizations
(Poster Num: P-M_73)
2. Bayerischer Tag der Telemedizin | 2. April 2014 in München
Das elektronische Tagebuch smart medication erlaubt ein einfaches und unmittelbares Monitoring bei der Heimselbstbehandlung in der Hämophilie. Dabei werden die Dokumentations- und Behandlungsanforderungen erfüllt. Der Blutungsverlauf wird konsequent und unmittelbar analysiert und ausgewertet.
W. Mondorf, C. Mondorf, H. Pollmann, B. Siegmund, A. Rösch, D. Schmoldt. (Poster Nr. 39)
POSTERBEITRÄGE 2013
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
GTH Tagung 2013
57. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) vom 20.-23. Februar 2013 in München. Posterpräsentation: “High acceptance of smart medication as telemetric tool for surveillance and treatmentin haemophilia home care”.
Mondorf W., Pollmann H., Siegmund B., Schmoldt D., Roesch A. (Poster Num.: P2-25)
POSTERBEITRÄGE 2012
Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:
WFH 2012 | World Congress in Paris | 8.-12. Juli 2012
smart medication – a new telemetric smartphone application for monitoring and evaluation of hemophilia home treatment. Hemophilia A and B are rare diseases and require medical care in specialized treatment centers. Because of long distances between patients and hemophilia center, telemedicine may be helpful to bring the right patient to the right doctor. Bleeding or treatment problems, usually reported during consultation at the hemophilia center, may be identified earlier and close to when they occur. Automated documentation and online analysis of the data is less time consuming and helps to avoid documentation errors.
W. MONDORF, H. POLLMANN, B. SIEGMUND, D. SCHMOLDT and A. RÖSCH; Haemostas, Frankfurt; ITH–Institut für Thrombophilie und Hämostaseologie, Münster; Philipps-Universität, Marburg, Germany. (Poster Num.: PO-MO-01)
GTH Tagung 2012
Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH). 01.-04. Februar 2012, St. Gallen/Schweiz. Improved surveillance of haemophilia home treatment using a telemetric smartphone application.
D. Schmoldt, A. Rösch (Philipps-Universität Marburg, Germany)
W. Mondorf (Haemostas, Frankfurt, Germany)
H. Pollmann, B. Siegmund (ITH – Institut für Thrombophilie und Hämostaseologie, Münster)
(Poster Num.: P2-59)
POSTERBEITRÄGE 2011
ISTH 2011 Kyoto, Japan
XXIII Congress of the International Society on Thrombosis and Haemostasis and 57th Annual Meeting of the Scientific and Standardization Committee of the ISTH, 23.-28.07.2011. Implementation of a telemetric smartphone application for improved surveillance of hemophilia home treatment.
A. Rösch, D. Schmoldt, W. Mondorf, H. Pollmann (Poster Num: P-TU-48)
